Sean Spicer and Dr. Jessica Duncan discuss the medical and political implications of peptide therapy, sparked by recent comments from the public health sector. The conversation clarifies that while peptides are naturally occurring amino acid chains, the current focus is on synthetic versions that have faced strict regulatory hurdles and limited availability since 2023. Dr. Duncan explains that the FDA is currently reviewing the science behind these substances, with the potential to reclassify and reintroduce numerous restricted peptides to the legal market shortly. Central to the dialogue is the necessity of professional medical oversight, as the speakers warn against the dangers of obtaining these potent compounds from unregulated "alternative markets" or social media influencers.
Learn more about your ad choices. Visit megaphone.fm/adchoices
